Q3 2019
Released Oct 24, 2019, after the close
10-Q filed Oct 24, 2019, 24 days after period end · 0001564590-19-037792
Q3 2019 · 10-Q
Revenue—
Net Income-$2.38M-$2.38M N/M vs Q3 2018N/M vs Q2 2019
EPS Diluted-$0.05-$0.05 N/M vs Q3 2018N/M vs Q2 2019
Operating Income-$2,645,565N/M
Operating Cash Flowderived-$2,039,005N/M
Free Cash Flowderived-$2,039,005N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Net Income | -$2.38M | -$6.78M | -$3.76M | -$2.84K |
| EPS Diluted | -$0.05 | -$0.16 | -$0.11 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medicinova Inc · CIK 1226616 · Engraved from SEC EDGAR